1536.00 - 1565.00
1090.00 - 1784.00
46.2K / 155.6K (Avg.)
23.48 | 66.41
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-55.89%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
-45.42%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
-98.53%
Negative EBIT growth while 6247.T is at 15.99%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-102.86%
Negative operating income growth while 6247.T is at 8.51%. Joel Greenblatt would press for urgent turnaround measures.
-117.37%
Negative net income growth while 6247.T stands at 20.25%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-117.36%
Negative EPS growth while 6247.T is at 20.31%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-117.36%
Negative diluted EPS growth while 6247.T is at 20.31%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
148.41%
10Y revenue/share CAGR above 1.5x 6247.T's 67.55%. David Dodd would confirm if management’s strategic vision consistently outperforms the competitor.
137.49%
5Y revenue/share CAGR above 1.5x 6247.T's 10.56%. David Dodd would look for consistent product or market expansions fueling outperformance.
70.80%
3Y revenue/share CAGR above 1.5x 6247.T's 22.46%. David Dodd would confirm if there's an emerging competitive moat driving recent gains.
100.00%
Positive long-term OCF/share growth while 6247.T is negative. John Neff would see a structural advantage in sustained cash generation.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
75.64%
Below 50% of 6247.T's 244.60%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
68.35%
5Y net income/share CAGR at 75-90% of 6247.T's 79.28%. Bill Ackman would advocate improvements to match competitor’s profit expansion.
-112.07%
Negative 3Y CAGR while 6247.T is 84.31%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
336.54%
10Y equity/share CAGR above 1.5x 6247.T's 49.37%. David Dodd would confirm if consistent earnings retention or fewer write-downs drive this advantage.
48.43%
5Y equity/share CAGR above 1.5x 6247.T's 2.54%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
32.40%
3Y equity/share CAGR above 1.5x 6247.T's 11.86%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-24.24%
Both reduce receivables yoy. Martin Whitman suspects a shift in the entire niche’s credit approach or softer demand.
11.79%
Inventory shrinking or stable vs. 6247.T's 27.68%. David Dodd confirms the company’s supply-chain is more efficient if sales are unaffected.
-5.75%
Negative asset growth while 6247.T invests at 0.70%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
-0.41%
We have a declining book value while 6247.T shows 1.24%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
-6.79%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
-100.00%
Both reduce R&D yoy. Martin Whitman sees an industry shifting to cost reduction or limited breakthroughs in the near term.
-11.69%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.